Southland Equity Partners LLC Abb Vie Inc. Transaction History

Southland Equity Partners LLC

$411 Billion
Q3 2024

A detailed history of Southland Equity Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Southland Equity Partners LLC holds 24,491 shares of ABBV stock, worth $4.11 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

24,491

Previous 17,755 37.94%

Holding current value

$4.11 Million

Previous $3.05 Billion 58.82%

% of portfolio

1.18%

Previous 0.87%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $1.1 Million - $1.34 Million	6,736 Added 37.94%	24,491 $4.84 Billion
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $1.56 Million - $1.82 Million	10,078 Added 131.28%	17,755 $3.05 Billion
Q1 2024 Apr 12, 2024	BUY	$159.82 - $182.1 $236,693 - $269,690	1,481 Added 23.9%	7,677 $1.4 Billion
Q4 2023 Jan 09, 2024	SELL	$137.6 - $154.97 $43,344 - $48,815	-315 Reduced 4.84%	6,196 $960 Million
Q3 2023 Jan 02, 2024	BUY	$133.59 - $154.65 $18,301 - $21,187	137 Added 2.15%	6,511 $970 Million
Q2 2023 Jan 02, 2024	BUY	$132.51 - $164.9 $246,998 - $307,373	1,864 Added 41.33%	6,374 $859 Million
Q1 2023 Jan 02, 2024	SELL	$144.61 - $166.54 $6,218 - $7,161	-43 Reduced 0.94%	4,510 $719 Million
Q4 2022 Jan 02, 2024	BUY	$138.31 - $165.87 $64,175 - $76,963	464 Added 11.35%	4,553 $736 Million
Q3 2022 Jan 02, 2024	SELL	$134.21 - $153.93 $25,231 - $28,938	-188 Reduced 4.4%	4,089 $549 Million
Q2 2022 Jan 02, 2024	BUY	$137.62 - $174.96 $9,771 - $12,422	71 Added 1.69%	4,277 $655 Million
Q1 2022 Jan 02, 2024	BUY	$131.98 - $163.75 $659 - $818	5 Added 0.12%	4,206 $682 Million
Q4 2021 Jan 02, 2024	BUY	$107.43 - $135.93 $9,883 - $12,505	92 Added 2.24%	4,201 $569 Million
Q3 2021 Jan 02, 2024	BUY	$106.4 - $120.78 $16,279 - $18,479	153 Added 3.87%	4,109 $443 Million
Q2 2021 Jan 02, 2024	BUY	$105.21 - $117.21 $526 - $586	5 Added 0.13%	3,956 $446 Million
Q1 2021 Jan 02, 2024	BUY	$102.3 - $112.62 $18,004 - $19,821	176 Added 4.66%	3,951 $428 Million
Q4 2020 Jan 02, 2024	BUY	$80.49 - $108.67 $303,849 - $410,229	3,775 New	3,775 $404 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Southland Equity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Southland Equity Partners LLC with notifications on news.

Account

Southland Equity Partners LLC Abb Vie Inc. Transaction History